摘要
目的探讨1例重症肺炎合并血流感染患者的药物治疗方法和思路。方法通过查阅相关指南及文献,结合该患者的病情特点,对其诊治及药物治疗调整方案进行分析及建议。结果患者初始抗感染治疗后效果不佳,合并血流感染后改用替考拉宁联合利奈唑胺治疗,经调整治疗方案后好转出院。结论重症患者发生血流感染常较危急,早期的诊治和个体化治疗是关键。
OBJECTIVE To investigate the drug treatment of a case of severe pneumonia complicated with bloodstream infection.METHODS Through consulting the relevant guidelines and literature,combined with the characteristics of the patient's condition,the diagnosis and treatment and drug treatment adjustment plan were analyzed and suggested.RESULTS After the initial anti-infective treatment was not effective,the patient was treated with teicolanin combined with linezolid after blood flow infection.After adjustment of treatment regimen,the patient was discharged with improvement.CONCLUSION Blood flow infection in severe patients is often critical,early diagnosis and treatment and individual treatment are the keys.
作者
翁斯豪
梁虹艺
WENG Sihao;LIANG Hongyi(Marine Corps Hospital of PLA,Chaozhou,Guangdong 521000,China;General Hospital of PLA Southern Theater Command,Guangzhou,Guangdong 510000,China)
出处
《今日药学》
CAS
2023年第11期874-876,共3页
Pharmacy Today
基金
广东省医学科学技术研究基金(A2022342)。
关键词
肺炎
血流感染
联合用药
达托霉素
pneumonia
bloodstream infection
combination medications
dattomycin
